Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  8,410 results for ""MYELOPROLIFERATIVE disorders""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'.

  • Authors : Mehta D; University College Hospital, University College of London Hospitals NHS Foundation Trust, London NW1 2BU, UK.; Alimam S

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/complications

  • Source: Current research in translational medicine [Curr Res Transl Med] 2024 Mar; Vol. 72 (1), pp. 103420. Date of Electronic Publication: 2023 Oct 13.Publisher: Elsevier-Masson SAS Country of Publication: France NLM ID: 101681234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Treatment outcome and germline predictive factors of ropeginterferon alpha-2b in myeloproliferative neoplasm patients.

  • Authors : Chen CC; Division of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Subjects: Neoplasms* ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/drug therapy ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e7166.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.

  • Authors : Collins TB; Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.; Laranjeira ABA

Subjects: Neoplasms* ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/metabolism

  • Source: Experimental hematology [Exp Hematol] 2024 Apr; Vol. 132, pp. 104178. Date of Electronic Publication: 2024 Feb 09.Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.

  • Authors : Wang J; Department of Internal Medicine, Hebei North University, Zhangjiakou, China.; Xu L

Subjects: Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/diagnosis ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/drug therapy ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Apr; Vol. 65 (4), pp. 521-525. Date of Electronic Publication: 2023 Dec 29.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.

  • Authors : Bhuria V; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany. .; Health-Campus Immunology, Infectiology, and Inflammation (GC-I3), Medical Center, Otto-von-Guericke University, Magdeburg, Germany. .

Subjects: Calcium* ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/metabolism

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 21; Vol. 22 (1), pp. 186. Date of Electronic Publication: 2024 Mar 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

Record details

Read More Add to Saved list
×
Academic Journal

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.

  • Authors : Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ong F

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/epidemiology ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/epidemiology

  • Source: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7093.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.

  • Authors : Trottier AM; Division of Hematology, Department of Medicine, QEII Health Sciences Centre, Dalhousie University, Halifax, NS, Canada.; Feurstein S

Subjects: Myelodysplastic Syndromes* ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/diagnosis ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics

  • Source: Best practice & research. Clinical haematology [Best Pract Res Clin Haematol] 2024 Mar; Vol. 37 (1), pp. 101537. Date of Electronic Publication: 2024 Feb 01.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120659 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms.

  • Authors : El Bitar S; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Arcasoy MO

Subjects: Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/drug therapy ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics; United States

  • Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Mar; Vol. 22 (2), pp. 80-89.Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.

  • Authors : England JT; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. .; Division of Medical Oncology & Malignant Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. .

Subjects: Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/genetics ; Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/therapy ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/genetics

  • Source: Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 570-578. Date of Electronic Publication: 2024 Feb 06.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Noonan Syndrome-related Myeloproliferative Disorder Occurring in the Neonatal Period: Case Report and Literature Review.

Subjects: Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/complications ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/diagnosis ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/genetics

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Mar 01; Vol. 46 (2), pp. e176-e179. Date of Electronic Publication: 2023 Dec 22.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  8,410 results for ""MYELOPROLIFERATIVE disorders""